Literature DB >> 23328976

IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression.

Cheng Cheng Huang1, Amy Lehman, Alia Albawardi, Anjali Satoskar, Sergey Brodsky, Gyongyi Nadasdy, Lee Hebert, Brad Rovin, Tibor Nadasdy.   

Abstract

Recent breakthrough findings revealed that most patients with idiopathic (primary) membranous glomerulonephritis have IgG4 antibodies to the phospholipase A2 receptor (PLA2R). These IgG4 antibodies can be detected in the glomerular immune complexes and they colocalize with PLA2R. In secondary forms of membranous glomerulonephritis, such IgG4 antibodies are absent or less prevalent. There are no studies addressing the IgG subclass distribution across different stages of membranous glomerulonephritis. During a 25-month period, we identified 157 consecutive biopsies with membranous glomerulonephritis with adequate tissue for light, immunofluorescence and electron microscopy. Of the 157 membranous glomerulonephritis cases, 114 were primary membranous glomerulonephritis and 43 were secondary membranous glomerulonephritis. We compared the intensity of IgG subclass staining (on a semiquantitative scale of 0 to 3+) and the IgG subclass dominance between primary and secondary membranous glomerulonephritis and between the different stages of membranous glomerulonephritis. In primary membranous glomerulonephritis most (76% of cases) were IgG4 dominant. In contrast, in secondary membranous glomerulonephritis IgG1 was dominant in 60% of biopsies (P=0.0018). Interestingly, in early stage (stage 1) primary membranous glomerulonephritis, IgG1 was the dominant IgG subclass (64% of cases); in all later stages IgG4 dominated (P=0.0493). It appears that there is an inverse relationship between the intensity of glomerular capillary IgG4 and C1q staining. In secondary forms of membranous glomerulonephritis (heterogeneous group with low case numbers), we did not find such associations. Our data indicate that in early stage membranous glomerulonephritis, antibody response is different from later stages, with IgG1 dominant deposits. It is possible that early on, antigens other than PLA2R have an important role, Alternately, there may be an IgG subclass switch in the antibody response with IgG4 taking over later as the dominant immunoglobulin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23328976     DOI: 10.1038/modpathol.2012.237

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  59 in total

1.  Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.

Authors:  Vincenzo L'Imperio; Federico Pieruzzi; Renato Alberto Sinico; Manuela Nebuloni; Antonio Granata; Andrew Smith; Antonella Radice; Fabio Pagni
Journal:  J Nephrol       Date:  2018-04-06       Impact factor: 3.902

2.  Reappraisal of PLA2R1 in membranous nephropathy: immunostaining method influence and association with IgG4-dominant phenotype.

Authors:  Shigeo Hara; Shunsuke Goto; Nozomu Kamiura; Akihiro Yoshimoto; Takayuki Naito; Naoko Imagawa; Yukihiro Imai; Motoko Yanagita; Shinichi Nishi; Tomoo Itoh
Journal:  Virchows Arch       Date:  2015-03-28       Impact factor: 4.064

3.  Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy.

Authors:  Peter D Burbelo; Megha Joshi; Adrija Chaturvedi; Dustin J Little; John S Thurlow; Meryl Waldman; Stephen W Olson
Journal:  J Am Soc Nephrol       Date:  2019-12-16       Impact factor: 10.121

4.  Combined Assessment of Phospholipase A2 Receptor Autoantibodies and Glomerular Deposits in Membranous Nephropathy.

Authors:  Hua-Zhang Qin; Ming-Chao Zhang; Wei-Bo Le; Qiang Ren; Da-Cheng Chen; Cai-Hong Zeng; Lei Liu; Ke Zuo; Feng Xu; Zhi-Hong Liu
Journal:  J Am Soc Nephrol       Date:  2016-03-17       Impact factor: 10.121

Review 5.  Immunopathogenesis of membranous nephropathy: an update.

Authors:  Hanna Debiec; Pierre Ronco
Journal:  Semin Immunopathol       Date:  2014-04-09       Impact factor: 9.623

6.  Anti-phospholipase A₂ receptor antibodies in recurrent membranous nephropathy.

Authors:  A Kattah; R Ayalon; L H Beck; S Sethi; D G Sandor; F G Cosio; M J Gandhi; E C Lorenz; D J Salant; F C Fervenza
Journal:  Am J Transplant       Date:  2015-03-12       Impact factor: 8.086

7.  Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese.

Authors:  Norifumi Hayashi; Shin'ichi Akiyama; Hiroshi Okuyama; Yuki Matsui; Hiroki Adachi; Hideki Yamaya; Shoichi Maruyama; Enyu Imai; Seiichi Matsuo; Hitoshi Yokoyama
Journal:  Clin Exp Nephrol       Date:  2014-12-10       Impact factor: 2.801

Review 8.  Membranous nephropathy: from models to man.

Authors:  Laurence H Beck; David J Salant
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

9.  Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy.

Authors:  Barbara Seitz-Polski; Guillaume Dolla; Christine Payré; Christophe A Girard; Joel Polidori; Kevin Zorzi; Eléonore Birgy-Barelli; Perrine Jullien; Cécile Courivaud; Thierry Krummel; Sylvia Benzaken; Ghislaine Bernard; Stéphane Burtey; Christophe Mariat; Vincent L M Esnault; Gérard Lambeau
Journal:  J Am Soc Nephrol       Date:  2015-11-13       Impact factor: 10.121

Review 10.  Immunology of membranous nephropathy: from animal models to humans.

Authors:  R A Sinico; N Mezzina; B Trezzi; G M Ghiggeri; A Radice
Journal:  Clin Exp Immunol       Date:  2015-11-24       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.